echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Libang instrument, Murray biological, Wanfu, "fight" up!

    Libang instrument, Murray biological, Wanfu, "fight" up!

    • Last Update: 2018-01-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medicine network January 16th, the end of this year, I medical device circle is very unevenMedical supplies control fees are not ending, medical device enterprises between the intellectual property case againfrom Guangdong A-share listed arms enterprise Libang instrument, in the name of patent infringement, will be in Guangdong with the domestic equipment enterprise leader Meirui Biological, as well as A-share listed arms enterprise Wanfu Biological have been brought to courtand Murray brought the previous patent war with Libang back, taking Libang to court, saying it had not stopped the infringement after the court's rulingto Libang as the main war party, the domestic medical and armed circleintellectual patent disputes again make wavesRight and wrong, will go where, everything is not good to say, who wins and who loses, the result is probably only the court to seeas a special field, in recent years, patent disputes are more and more,on intellectual property rights are also more and more attentionVarious intellectual property disputes between medical device companies, can only query the court's judgment results on a lot, Libang VS Murray, Libang VS Wanfu, is not the only caseThis is the inevitable intensification of market competitiononly wish a court case, the industry, enterprises can be standardized and promoted, rather than leaving a place of chicken hair, win may not win, lose and lose may not be lost, patent infringement chaos is still difficult to understandyesterday (January 15), Shenzhen Libang Precision Instruments Co., Ltdissued a notice that it has filed a lawsuit with the Fuzhou Branch of Shenzhen Meirui Biomedical Electronics Co., Ltdand Shenzhen Meirui Biomedical Electronics Co., Ltdto the Fuzhou Intermediate People's Court of Fujian ProvinceThe Case was accepted by the Fuzhou Central Courtlibon sued Murray for a total of four patents Libang said that the patentee in the case, Murray unauthorized manufacture and/or sale, promised to sell the alleged infringing products, to Libang caused serious damage Libang's claim, ordering Merui to immediately stop manufacturing, selling, promising to sell alleged infringing products, and to compensate Libang for economic losses totalling 100 million yuan remembers that since April 2011, Murray has launched an intellectual property lawsuit against Libang, which was fought for a full five-and-a-half years until the end of 2016 when the Guangdong High Court made a final judgment Murray initiated a total of 24 lawsuits, after the withdrawal of 12 cases, the remaining 12 Murray all won the case, won more than 28 million yuan these two well-known enterprises in the industry with deep roots, because of a "patent war" caused strong concern in the industry, outside the industry Who would have thought that the "patent war" had virtually not ended when the final judgment was handed down more than a year ago Shortly before the (December 8, 2017), Libang issued a notice that it had received information on the response notice in three cases served by the Shenzhen Intermediate People's Court of Guangdong Province The Shenzhen Central Court has accepted the case of Mei Rui's prosecution and prosecution of libang for infringement of the patent rights of inventions, and the infringement of technical secret disputes Murray sued Libang, who sued the court in late 2016 for a final judgment on the "patent war", but Libang has not stopped the infringement during and after the trial related infringing products, including the invention patent of "a portable ultrasound diagnostic instrument" and "electronic noninvasive blood pressure measurement device", as well as the technical secret of electrocardiogram algorithm, involving products ranging from ultrasound diagnosticinstruments to multi-parameter monitors Myri's claim, the judgment libang immediately stop the infringement, immediately stop the production, sales of the infringement of Myer's trade secrets of multi-parameter monitor, and compensate Myer's economic losses totalling more than 14.3 million yuan last big fight, Murray overpowered the state This time, Murray sued Libang, ignoring the court ruling to continue to infringe; The two are each other's plaintiffs, defendants, particularly lively The main field of warfare products is the monitor and this patent war, which has both old and new ones, will be fought for years? take a look at another patent lawsuit in the medical device sector that also happened this winter November 28, 2017, Libang announced that it has filed a lawsuit with the Guangzhou Intellectual Property Court in disputes with Guangzhou Wanfu Biotechnology Co., Ltd and Guangzhou Haifu Medical Technology Co., Ltd (Wanfu Holdings subsidiary) The Guangzhou Intellectual Property Court accepted the relevant cases December 5, 2017, Libang issued a further notice, said that the company and Guangzhou Wanfu Biotechnology Co., Ltd and natural person Wang Jihua in the patent application dispute, to the Guangzhou Intellectual Property Court The Guangzhou Intellectual Property Court accepted the relevant cases Libang also told the wanfu creature in Guangdong Province Libang sued Wanfu, a total of 3 patents, 4 patent applications, the main field of war products is "blood gas analyzer." Libang said that Wanfu manufacturing, sales, promised sales of blood gas analyzer products, including analyzers, test cards, reagent kits, quality control kits, etc., constitute a patent infringement of Libang, causing huge losses to Libang Libang's claim, ordered Wanfu to immediately stop manufacturing, selling, promising to sell alleged infringing products, and compensation for Libang economic losses totalling 20 million yuan also said that in March 2016, Wanfu filed four patent applications with the State Intellectual Property Office, the inventor of which was a former Libang employee Two persons joined Wanfu after leaving their posts and, less than one year after leaving, filed a patent application in the name of Wanfu for technical content related to their work in Libang Later, in order to disguise the relevant facts, Wanfu changed the inventor and named another person as the patented inventor Libang's claim, ordered Wanfu to apply for four patent applications involving the right to belong to Libang, and ordered that the other person is not the inventor of the patent application involved 's announcement of the suit against Libang, Wanfu publicly responded that the company's blood gas detection system by its own Research and Development team in China and the United States after many years of independent development, the company believes that there is no infringement If the court issued an indictment and other relevant documents, the company will respond to the law, in order to safeguard the legitimate rights and interests of the company.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.